Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.
about
Genes, tolerance and systemic autoimmunityApplication of IgG-derived natural Treg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetesFoxp3+ regulatory T cells are required for recovery from severe sepsisBlockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like diseaseUpregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviationStreptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking.Therapeutic potential of TGF-β-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases.CD8+ Tregs in lupus, autoimmunity, and beyond.Common gamma chain cytokines promote rapid in vitro expansion of allo-specific human CD8+ suppressor T cellsModulation of autoimmunity with artificial peptidesMurine models of systemic lupus erythematosusLactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis.Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.Interferon-inducible gene 202b controls CD8(+) T cell-mediated suppression in anti-DNA Ig peptide-treated (NZB × NZW) F1 lupus mice.Human and Mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at Steady State and during Interleukin-2 TherapyCD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice.CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.Cytokines in systemic lupus erythematosusRegulation of apoptosis-related genes by nitric oxide in cancer.Advancements in immune toleranceInhibitory CD8+ T cells in autoimmune diseaseInduction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone miceRegulatory T cells in systemic lupus erythematosus: past, present and future.Novel targets for immunotherapy in glomerulonephritis.Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells.Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation.Treating autoimmune disease by targeting CD8(+) T suppressor cellsDifferential role of all-trans retinoic acid in promoting the development of CD4+ and CD8+ regulatory T cells.Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells.Regulatory T cells and immune tolerance to tumors.Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity.In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity.Immune tolerance and transplantation.The role of regulatory T cells in the biology of graft versus host disease.Regulatory T cells in colorectal cancer: from biology to prognostic relevance.Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells.Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer.
P2860
Q24615454-03E696E0-AD54-4510-9842-5C5D79109D77Q24627149-715442AB-C31B-4E4E-93DB-9E6016BD643CQ27317316-88DAF513-2AD8-4D72-8606-74BAA0C1B230Q28590296-87F8F245-E73F-40AA-B514-91C2FC41EE0EQ33371835-2CF3D756-13E4-46A8-B1D6-98BF4680178BQ33506614-C8FD8E89-EF37-4511-94CF-F5AD4C663C69Q33684806-1E70404D-7430-49AB-838F-BD5EB337DF05Q33889097-A3DF36A4-126D-46EC-92C1-F086D7A42474Q34110557-2D6D9237-D54B-4F7D-BCC8-68D2E6A479B2Q34288089-412B0602-BAB0-4E79-B67A-F4377EAF60B6Q34591019-55F32701-AF9F-43DD-90A2-45D394094E3EQ34598916-9CBAB73D-293F-47DB-B8D6-20499FBFCC7EQ34600950-0DEDF433-2259-4881-B35D-BDC6AB84BB39Q35146773-07A334B7-4066-4981-8154-C4B636B82A1AQ35426986-2E35279B-C814-47C6-A7E9-053CEEFAF622Q35944770-EE531109-E647-4229-A380-689FE9D96A32Q36055096-756FF4ED-993E-455C-AED9-54E2A4C1E375Q36659210-3DEA4430-2EBC-4955-9FC1-EC3C374127B1Q36876734-3A3738D7-93B2-4A27-8E78-82D880A9399AQ36988746-37285C86-FFE8-4D34-B252-B719A17CCA05Q37037612-2B5479C0-E839-498A-A790-41D4E3574DA3Q37052040-E5632573-FC9A-4F13-83F9-44318C582427Q37129619-914F24A9-6381-4A84-A849-60F42718AEE1Q37290692-E62971D1-F10E-4EA8-B787-3909B76B76D9Q37366061-2F26F017-2E7D-489F-B01B-6748E7B3A8BBQ37366068-6694E2B2-97CC-4055-B3B0-E0523E09DC2AQ37379313-A5C9F13E-8D41-4571-9AEB-928B83F6B08FQ37414507-DBD91B7A-271B-4DEA-9F8D-F126FDE34195Q37467452-F6AF2678-EDBB-4525-9B69-DE95B73A0694Q37496796-43419A8F-1448-4E8A-9373-BB066EDC96E5Q37590759-0FAE02B9-E0DC-48F5-9FDE-B4112486D94CQ37599669-8F155CE8-D3D0-442E-893B-428224E69B85Q37773268-F96D30E2-6F15-4D64-8AEA-C6AE062BBE8CQ37776500-2ED843C6-BB08-4777-93FB-2C6F0EB73869Q38039963-59029C5C-22EE-4989-93DF-AA44F430086AQ38064621-979470DF-3DE1-4612-9A32-CE8A4CE1975FQ38117369-EC7EE358-EBCB-40DD-9975-1369688A2DC5Q38161354-F2C5A44E-5F1A-492C-AF26-6C38FDCCE5A8Q42091259-2B140167-7AB7-4092-9B2E-67E8DDDD8816Q43916071-96AC2BC6-5006-4E10-B7EB-BDF0B783BBE9
P2860
Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Tolerogenic treatment of lupus ...... eting CD8+ T cell suppressors.
@en
Tolerogenic treatment of lupus ...... eting CD8+ T cell suppressors.
@nl
type
label
Tolerogenic treatment of lupus ...... eting CD8+ T cell suppressors.
@en
Tolerogenic treatment of lupus ...... eting CD8+ T cell suppressors.
@nl
prefLabel
Tolerogenic treatment of lupus ...... eting CD8+ T cell suppressors.
@en
Tolerogenic treatment of lupus ...... eting CD8+ T cell suppressors.
@nl
P2093
P1476
Tolerogenic treatment of lupus ...... eting CD8+ T cell suppressors.
@en
P2093
Antonio La Cava
Bevra H Hahn
Fanny M Ebling
Ram Pyare Singh
P304
P356
10.4049/JIMMUNOL.175.11.7728
P407
P577
2005-12-01T00:00:00Z